UNION is a privately held, clinical stage, pharmaceutical company dedicated to the development of molecules exhibiting both microbiological and immunomodulatory effects. UNION is focused on the treatment of inflammatory skin disease, but the chemistry platform and its versatile mode of action is widely applicable across a wide range of diseases.


Providing effective treatment options for patients by attracting, developing, and retaining world class expertise to be a sustainable innovator at the intercept of microbiology and immunology


Learn more